Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance?
The goal of this commentary is to review the most relevant topics concerning the clinical utility of ambulatory blood pressure (BP) monitoring, such as the state of the art "reference BP values", the importance of the discrepant situations between office and ambulatory BP (white-coat and masked hypertension) and those of the recommended clinical indications to now. From a small number of studies, operational thresholds to define hypertension have been established. They are useful tools even though more studies are necessary to create strong reference values. Ambulatory BP measurement is increasingly recognized as being indispensable to the diagnosis and management of hypertension, and it has contributed significantly to our understanding of hypertension by revealing or "unmasking" BP phenomena that were not readily apparent using traditional techniques of measurement in clinical practice. Ambulatory BP monitoring should be performed in adolescents with either office mild essential hypertension before starting antihypertensive drug treatment or a strong family history of hypertension or an early cardiovascular event. Obese children with normal office BP values will also benefit from ambulatory BP monitoring. Other indications are the assessment of refractory hypertension or drug-induced hypotension. Finally, additional BP information in chronic renal failure, diabetes, and autonomic neuropathy can be obtained by using ambulatory BP monitoring.
Lurbe
Empar
E
Redon
Josep
J
D000293:Adolescent; D018660:Blood Pressure Monitoring, Ambulatory; D003937:Diagnosis, Differential; D006801:Humans; D006973:Hypertension / Q000175:diagnosis* / Q000523:psychology; D009819:Office Visits
Pediatrics. 1987 Jan;79(1):1-25
3797155
J Pediatr. 2004 Jan;144(1):7-16
14722512
JAMA. 1988 Jan 8;259(2):225-8
3336140
Pediatrics. 1996 Oct;98(4 Pt 1):649-58
8885941
Hypertension. 2005 Apr;45(4):481-2
15790959
Am J Hypertens. 1998 Apr;11(4 Pt 1):410-7
9607378
Pediatrics. 2004 Aug;114(2 Suppl 4th Report):555-76
15286277
Hypertension. 2005 Apr;45(4):493-8
15767467
Arch Intern Med. 1988 May;148(5):1023-38
3365073
Hypertension. 2000 Mar;35(3):807-13
10720599
J Hypertens. 2002 Oct;20(10):1995-2007
12359978
JAMA. 2004 Mar 17;291(11):1342-9
15026401
Lancet. 1990 Mar 31;335(8692):765-74
1969518
J Hypertens. 2006 Aug;24(8):1557-64
16877958
Hypertension. 2006 May;47(5):820-1
16567587
Hypertension. 2002 Dec;40(6):795-6
12468559
Circulation. 2003 Mar 11;107(9):1297-302
12628951
J Hypertens. 2003 Nov;21(11):2001-3
14597838
J Pediatr. 2000 May;136(5):578-86
10802487
J Hypertens. 1994 Dec;12(12):1417-23
7706703
Hypertension. 2006 May;47(5):846-53
16567588
Am J Hypertens. 2001 Sep;14(9 Pt 1):855-60
11587149
J Fam Pract. 1991 Dec;33(6):617-23
1744607
J Hypertens Suppl. 1985 Nov;3(2):S5-11
3866844
J Hypertens Suppl. 2003 May;21(2):S11-8
12929902
Pediatr Nephrol. 2005 Aug;20(8):1151-5
15947982
J Hypertens. 1997 Jan;15(1):3-17
9050965
Circulation. 1975 Jun;51(6):1101-6
1132100
Am J Hypertens. 1995 Jul;8(7):657-65
7546488
Circulation. 2002 Jul 2;106(1):143-60
12093785
Lancet. 1988 Aug 13;2(8607):397
2899801